Endoscopic palliation of pancreatic adenocarcinoma

Current Opinion in Gastroenterology

Volumn 21, Issue 5, 2005, Pages 601-605

  Srikureja, Wichit ^a   Chang, Kenneth J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endoscopy; Palliation; Pancreatic adenocarcinoma

Indexed keywords

ALCOHOL; ANALGESIC AGENT; ANTINEOPLASTIC AGENT; BUPIVACAINE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; POLYETHYLENE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TNFERADE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; BILE DUCT OBSTRUCTION; BLEEDING; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CELIAC PLEXUS; CHOLANGITIS; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; DRUG ELUTING STENT; ENDOPROSTHESIS; FOREIGN BODY REACTION; GENE DELIVERY SYSTEM; GENE THERAPY; GENE VECTOR; HEALTH CARE COST; HUMAN; HYPOTENSION; INTESTINE PERFORATION; NEUROLYSIS; PANCREAS ADENOCARCINOMA; PARENTERAL NUTRITION; REVIEW; STOMACH OBSTRUCTION; SYMPATHETIC BLOCKING;

ADENOCARCINOMA; ENDOSCOPY, GASTROINTESTINAL; HUMANS; PALLIATIVE CARE; PANCREATIC NEOPLASMS;

EID: 23944512777     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000172750.05280.02     Document Type: Review

References (32)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
2. Engelken FJ, Bettschart V, Rahman MQ, et al. Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol 2003; 29:368-373.
3. Smith AC, Dowsett JF, Russell RC, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994; 344:1655-1660.
4. Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; 2:57-62.
5. Brandabur JJ, Kozarek RA, Ball TJ, et al. Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis. Am J Gastroenterol 1988; 83:1132-1139.
6. Shepherd HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988; 75:1166-1168.
7. Giorgio PD, Luca LD. Comparison of treatment outcomes between biliary plastic stent placements with and without endoscopic sphincterotomy for inoperable malignant common bile duct obstruction. World J Gastroenterol 2004; 10:1212-1214. This study examined whether endoscopic sphincterotomy is needed with insertion of bile duct stents. The authors conclude that sphincterotomies are not routinely needed.
8. Levy MJ, Baron TH, Gostout CJ, et al. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin Gastroenterol Hepatol 2004; 2:273-285. This is a systematic evidence-based review of published studies comparing plastic stents with SEMS for palliation of malignant biliary obstruction. The evidence suggests that SEMS should be considered when patients have expected survival of longer than 6 months.
9. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of 'covered' versus 'uncovered' diamond stents for the management of distal malignant biliary obstruction. Gut 2004; 53:729-734. The study compares 'covered' and 'uncovered' SEMS for palliation of malignant biliary obstruction. Although covered stents have lower rates of occlusion, they are associated with increased complications from acute cholecystitis and pancreatitis.
10. Bueno JT, Gerdes H, Kurtz RC. Endoscopic management of occluded biliary Wallstents: a cancer center experience. Gastrointest Endosc 2003; 58:879-884.
11. Prat F, Chapat O, Ducot B, et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 1998; 42:76-80.
12. Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003; 57:178-182.
13. Brasiunas V, Brasiuniene B, Juozaityte E, Barauskas G. Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer. Medicina (Kaunas) 2004; 40:1074-1080.
14. Baron TH. Surgical versus endoscopic palliation of malignant gastric outlet obstruction: big incision, little incision, or no incision? Gastroenterology 2004; 127:1268-1269.
15. Maetani I, Tada T, Ukita T, et al. Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy 2004; 36:73-78. This study compares placement of duodenal SEMS with standard gastrojejunostomies for palliation of malignant GOO in regards to different outcomes. The median time to resumption of oral intake was shorter in the stent group compared with the surgical group. Additionally, the performance status was improved more frequently in the stent group as compared with the surgical group.
16. Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antropyloric strictures: gastroenterostomy vs. endoscopic stenting: a randomized prospective trial. Anticancer Res 2004; 24:269-271.
17. Telford JJ, Carr-Locke DL, Baron TH, et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004; 60:916-920. The author conducted a retrospective review of patients who underwent placement of enteral SEMS for palliation of GOO from different endoscopic referral centers. The study identified the largest cohort to date. The majority of the patients with enteral SEMS have median duration of oral intake of 146 days. In addition, chemotherapy after enteral SEMS was independently associated with prolongation of oral intake.
18. Holt AP, Patel M, Ahmed MM. Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? Gastrointest Endosc 2004; 60:1010-1017.
19. Kaw M, Singh S, Gagneja H. Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction. Surg Endosc 2003; 17:457-461.
20. Lindsay JO, Andreyev HJ, Vlavianos P, Westaby D. Self-expanding metal stents for the palliation of malignant gastroduodenal obstruction in patients unsuitable for surgical bypass. Aliment Pharmacol Ther 2004; 19:901-905.
21. Mosler P, Mergener KD, Brandabur JJ, et al. Palliation of gastric outlet obstruction and proximal small bowel obstruction with self-expandable metal stents: a single center series. J Clin Gastroenterol 2005; 39:124-128.
22. Nassif T, Prat F, Meduri B, et al. Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy 2003; 35:483-489.
23. Mittal A, Windsor J, Woodfield J, et al. Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg 2004; 91:205-209.
24. Klapman JB, Chang KJ. Endoscopic ultrasound-guided fine-needle injection. Gastrointest Endosc Clin North Am 2005; 15:169-177. The authors reviewed the clinical applications of endoscopic ultrasound-guided fine-needle injection in various settings. Pertinent to palliation of pancreatic adenocarcinoma is the discussion of techniques of CPN and endoscopic ultrasound-guided delivery of chemotherapy and vector for gene therapy.
25. Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc 1996; 44:656-662.
26. Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001; 54:316-324.
27. Gress F, Schmitt C, Sherman S, et al. A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol 1999; 94:900-905.
28. de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 2004; 110:400-408.
29. Lee DK, Kim HS, Kim KS, et al. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc 2005; 61:296-301.
30. Villaverde A, Cope C, Chopita N, et al. Long term follow-up of endoscopic gastroenteric anastomoses with magnets (EGAM). Gastrointest Endosc 2004; 59:AB92.
31. Chang KJ, Nguyen PT, Thompson JA, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000; 88:1325-1335.
32. Chang KJ, Senzer N, Chung T, et al. A novel gene transfer therapy against pancreatic cancer (TNFerade) delivered by endoscopic ultrasound (EUS) and percutaneous guided fine needle injection (FNI). Gastrointest Endosc 2004; 59:AB92.